| Keric, Amir (OLS Omni Life Science 201810 Product Manager) |
Product Manager (personnel) |
Omni Life Science (OLS) (Group) |
Germany |
| Kerl, Christopher (TU Hamburg-Harburg 201106 TuTech Innovation) |
n. a. |
Technical University Hamburg-Harburg (TUHH) |
Germany |
| Kern, Frieder (DKFZ 200512) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Kerouedan, Christelle (Coulter Partners 202109– Marketing Director before Instinctif Partners) |
Sales Manager / Marketing Manager |
Coulter Partners (The Coulter Partnership Ltd.) |
United Kingdom (GB) |
| Kerr, Mary (Nerre Therapeutics 201510– CEO before GSK + Advent Life Sciences) |
Chief Executive Officer (CEO) |
Nerre Therapeutics Ltd. |
United Kingdom (GB) |
| Kerr, Paul (Fusion Antibodies 201205 Managing Director) |
Managing Director |
Fusion Antibodies (Group) |
United Kingdom (GB) |
| Kerschbaumer, Randolf (OncoOne 202003 CEO + Co-Founder before Shire + Baxter BioScience) |
Chief Executive Officer (CEO) |
OncoOne Research & Development GmbH |
Austria |
| Kerski, Chris (Cardinal Health 201204 SVP + General Manager of Scientific Products) |
President/Director/Head Business Group/Unit/Division |
Cardinal Health (Group) |
United States (USA) |
| Kersten, Dirk (Forbion 201810– General Partner before Inkef Capital + Gilde Healthcare) |
General Partner (venture partner) |
Forbion (Group) |
Netherlands |
| Kersting, Michael (Vilder 201405 Managing Director of Vilbar Lourmat Deutschland GmbH) |
Managing Director |
Vilber (Group) |
Germany |
| Kessler, Peter (Sekisui 201201 Managing Director of Sekisui Virotech GmbH) |
Managing Director |
Virotech (DE) (Group) |
Germany |
| Kessler, Thomas (BRAIN 201507– Business Operations Unit before Merck KGaA) |
Business Manager |
BRAIN Biotech (Group) |
Germany |
| Kessler, Ulrich (Inthera Bioscience AG 201512 CEO + Co-founder) |
Chief Executive Officer (CEO) |
Inthera Bioscience AG |
Switzerland |
| Kessmann, Helmut (Polyphor 201812 Head Business Development joined 2011) |
Business Development Manager / Strategy Manager |
Spexis (Group) |
Switzerland |
| Ketschau, Guido (Ketschau Consulting before Impetus co-founder before Hanse Analytik co-founder) |
Company Founder |
Ketschau Consulting, Guido Ketschau |
Germany |
| Ketterlinus, Ralf (Omni Life Science 201402 before Bruker Daltonik GmbH LEFT 7/12) |
Sales Manager / Marketing Manager |
Omni Life Science (OLS) (Group) |
Germany |
| Kettler, Axel (Eppendorf 200809) |
Sales Manager / Marketing Manager |
Eppendorf (Group) |
Germany |
| Kettling, Ulrich (Cevec 202004 CBO) |
Chief Business Officer (CBO) |
Danaher (Group) |
Germany |
| Keywood, Charlotte (Zambon 201603 Head RnD before Addex Pharma CMO) |
Research & Development Manager |
Zambon (Group) |
Italy |
| Keßler Martin (Rentschler 202103– SVP Transformation + CEO of Rentschler Biopharma Inc before McKinsey & Co) |
Business Development Manager / Strategy Manager |
Rentschler (Group) |
Germany |
| Khairi-Taraki, Tarrin (Mainz Biomed 202310– VP of Commercial Operations EMEA) |
Sales Manager / Marketing Manager |
Mainz Biomed N.V. (Nasdaq: MYNZ) |
Germany |
| Khajooei, Mehran (Eppendorf AG 200806) |
Sales Manager / Marketing Manager |
Eppendorf (Group) |
Germany |
| Khalil, Iya (Novartis 202005– Global Head of AI Innovation Center before Co-Founder of GNS Healthcare) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
|
| Khaljani, Ehsan |
n. a. |
|
|
| Khanna, Rohit (Waters 201601– SVP Applied Technology before VP Worldwide Marketing) |
President/Director/Head Business Group/Unit/Division |
Waters (Group) |
United States (USA) |
| Khevenhueller Borghese, Camilla (IBI-Lorenzini 201609 CEO) |
Chief Executive Officer (CEO) |
Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. (IBI-Lorenzini) |
Italy |
| Kholmyansky, Ira (Kenes 201601 Industry Business Intelligence) |
n. a. |
Kenes (Group) |
Switzerland |
| Khuong, Chau Q. (OrbiMed Advisors 201411 Private Equity Partner joined OrbiMed 2003) |
Partner (venture partner) |
OrbiMed (Group) |
United States (USA) |
| Kick, Benjamin (Plectonic Biotech 202211 COO + Co-Founder) |
Chief Operating Officer (COO) |
Plectonic Biotech GmbH |
Germany |
| Kieback, Elisa (T-Knife 202101 CTO before 201711– Managing Director + Co-Founder) |
Chief Technology/Technical Officer (CTO) |
T-Knife (Group) |
Germany |
| Kiener, Peter A. (Sucampo + Ambrx + Zyngenia + MedImmune) |
Board member, non-executive |
Mallinckrodt (Group) |
United States (USA) |
| Kiesewetter, Ira (c-LEcta GmbH 201205 Public Relations) |
Public Relations Manager / Investor Relations Manager |
Kerry Group (Group) |
Germany |
| Kikinis, Ron (Harvard Medical School 201404 Prof + Fraunhofer 201405– Director of Fraunhofer MEVIS) |
Professor |
Harvard University |
United States (USA) |
| Kikukawa, Tsuyochi (Olympus 200607 President Oympus Corp) |
President/Director/Head Business Group/Unit/Division |
Olympus (Group) |
Japan |
| Kilby, Greg (Protea 201404– Chief Bioanalytics Officer before Thermo Fisher + Agilent + Pfizer) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Protea Biosciences (Group) |
United States (USA) |
| Kilger, Christian (Fanelli Haag & Kilger 201203– before Vossius & Partner Berlin + ipal GmbH + Lion Bioscience) |
Patent Attorney |
Fanelli Haag & Kilger PLLC |
Germany |
| Kilger, Ute (Boehmert & Boehmert Berlin 200908– Patent Attorney before Vossius & Partner Berlin before Schering) |
Patent Attorney |
Boehmert & Boehmert (Patentanwälte) (Group) |
Germany |
| Killer, Stefan (Kumovis 202005 Head of Marketing + Communications) |
Public Relations Manager / Investor Relations Manager |
3D Systems (Group) |
Germany |
| Kim, Grace (Rentschler 202002– VP BusDev North America & APAC before Northway Biotechpharma + Samsung Biologics) |
Business Development Manager / Strategy Manager |
Rentschler (Group) |
United States (USA) |
| Kim, J. Joseph (Inovio 200906 CEO before VGX Pharmaceuticals 200807 CEO + co-founder) |
Chief Executive Officer (CEO) |
Inovio (Group) |
United States (USA) |
| Kim, Phillip (Trutino Biosciences 202002 CEO + Founder) |
Chief Executive Officer (CEO) |
Trutino Biosciences Inc. |
United States (USA) |
| Kim, Sang-Hoon (Bukwang Pharmaceutical Co Ltd 201312 CEO) |
Chief Executive Officer (CEO) |
Bukwang (Group) |
Korea, Republic of |
| Kim, Sun (Centogene 201905– Chief Strategy & IR Officer before Shire + Novartis + Bausch & Lomb + McKinsey + AT Kearney) |
Corporate Strategy Manager |
Centogene (Group) |
United States (USA) |
| Kim, Susan (CRISPR Therapeutics 201809 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
CRISPR Therapeutics (Group) |
Switzerland |
| Kim, Tae-Han (Samsung 201205– CEO of Samsung BioLogics) |
Chief Executive Officer (CEO) |
Samsung |
Korea, Republic of |
| Kim, Wan-joo (Chem Tech Research 201310 CEO) |
Chief Executive Officer (CEO) |
Chem Tech Research Inc. (C-TRI) |
Korea, Republic of |
| Kimber, Ian (Syngenta UK 200601) |
n. a. |
Syngenta (Group) |
Switzerland |
| Kimmel, Kendra (TOFwerk 202205 Head of Marketing) |
Chief Commercial Officer (CCO) |
TOFwerk AG |
Switzerland |
| Kimura, Alan (CureVac 202002– Head of Rare Diseases before Enzyvant + SutroVax + Translate Bio + Shire + Novartis) |
President/Director/Head Business Group/Unit/Division |
CureVac (Group) |
Germany |
| Kimura, Keiji (Sony 201109 EVP + Executive Officer Sony Corp) |
Board member, executive |
Sony (Group) |
Japan |
| Kindervater, Ralf (BioPro 200503 Managing Director) |
Managing Director |
Baden-Württemberg (govt region) |
Germany |
| Kindler, Constanze (Qiagen 200705 Product Manager) |
Product Manager (personnel) |
Qiagen (Group) |
Germany |
| King, David P. (LabCorp 201707 CEO before COO joined 2001) |
Chief Executive Officer (CEO) |
LabCorp (Group) |
United States (USA) |
| King, Gary (Myriad 201501 EVP International Operations) |
n. a. |
Myriad Genetics (Group) |
United States (USA) |
| Kinsella, Kevin J. (Avalan Ventures 201506 Founder) |
Company Founder |
Avalon Ventures |
United States (USA) |
| Kintzel, Wolfgang (Ayoxxa 201802 Managing Director + Science to Market Venture Capital + CEVEC Pharmaceuticals + Direvo) |
Managing Director |
Ayoxxa (Group) |
Germany |
| Kipp, Bryan (PerkinElmer 201902 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
PerkinElmer (Group) |
United States (USA) |
| Kiprijanov, Sergej (Affitech 200802– Head of Research before Novoplant) |
Research & Development Manager |
Affitech (Group) |
Norway |
| Kiprov, Dobri (Lyfspn 202209 CSO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Lyfspn |
|
| Kirby, Julian (Bico 202207 Business Development Manager at Scienion UK) |
Business Development Manager / Strategy Manager |
Bico (Group) |
United Kingdom (GB) |
| Kirby, Leo (Baker Brothers 201108) |
n. a. |
Baker Brothers (Group) |
United States (USA) |
| Kirchheim, Ansgar (High-Tech Gründerfonds 201603 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Kirchhoff, Marcus (MeVis Medical Solutions 201203– CEO before GE Healthcare IT) |
Chief Executive Officer (CEO) |
Varian Medical Systems (Group) |
Germany |
| Kirchhoff, Petra (Sartorius 201401 VP Group Corporate Communications + IR) |
Public Relations Manager / Investor Relations Manager |
Sartorius (Group) |
Germany |
| Kirchhoff, Tobias (BCNP Consultants GmbH 202204– Managing Director before Senior Consultant) |
Consultant (economic/technology) |
BCNP Consultants GmbH |
Germany |
| Kirchmair, Johannes (Single Use Support 201911 Managing Director + Co-Founder) |
n. a. |
Single Use Support GmbH (SUS) |
Austria |
| Kirchner, Christian (Wallinger Ricker Schlotter Trastmann 201409 Patent Attorney) |
Patent Attorney |
Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte (WRST) |
Germany |
| Kirchner, Hellmut |
Managing Partner (investment firm) |
Sal. Oppenheim jr & Cie. KGaA |
Germany |
| Kirchner, Linda (Yumab 2002205 Head of Business + Finance + Corat Therapeutics 202207) |
Business Development Manager / Strategy Manager |
Yumab GmbH |
Germany |
| Kirchrath, Lutz (NuGEN 200904– Managing Director Europe before Affymetrix Europe before Amersham Pharmacia Freiburg) |
Managing Director |
Tecan (Group) |
United States (USA) |
| Kirjner, Carlos (Celonis 202106– CFO before Google + Sanford C Bernstein + McKinsey & Co) |
Chief Financial Officer (CFO) |
Celonis (Group) |
Germany |
| Kirk, Chris (SGS 201011 CEO) |
Chief Executive Officer (CEO) |
SGS (Group) |
Switzerland |
| Kirk, Randal J. (Intrexon 201502 CEO) |
Chief Executive Officer (CEO) |
Halozyme Therapeutics Inc. (Nasdaq: HALO) |
United States (USA) |
| Kirkwood, Karen (Thermo Fischer 201202 Media Relations) |
Public Relations Manager / Investor Relations Manager |
Thermo Fisher (Group) |
United States (USA) |
| Kirn, David (4D Molecular Therapeutics 201804 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
4D Molecular Therapeutics LLC (4DMT) |
United States (USA) |
| Kiron, Ravi (KineMed 201401 CBO) |
Chief Business Officer (CBO) |
KineMed Inc. |
United States (USA) |
| Kirsch, Harry (Novartis 201304– Group CFO before CFO of Novartis Pharmaceuticals) |
Chief Financial Officer (CFO) |
Novartis (Group) |
Switzerland |
| Kirsch, Heidrun (MolecularHealth 201405 Molecular Health GmbH) |
n. a. |
Molecular Health (Group) |
Germany |
| Kirschbaum, Bernhard (Merck Serono 200809 Executive VP Research) |
Research & Development Manager |
Merck (DE) (Group) |
Germany |
| Kirschenhofer, Florian (Max Planck 201509 Startup + Portolio Manager at Max Planck Innovation) |
IP Manager |
Max Planck Society for the Advancement of Science |
Germany |
| Kirst, Oliver (Servier 201711 General Manager of Servier Germany) |
General Manager (management) |
Servier (Group) |
Germany |
| Kissel, Karsten (Boehringer 201711 Head Global Medical Affairs Biosimilars) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Germany |
| Kitschin, Dana (Israel (govt) 201110 Israel Trade Center Berlin) |
n. a. |
Israel (govt) |
Germany |
| Kjøller, Kim (Leo Pharma 201201 SVP Global Development) |
Research & Development Manager |
Leo Pharma (Group) |
Denmark |
| Klaften, Matthias (Amcure GmbH 201202– Managing Director + Co-founder) |
Managing Director |
Amcure GmbH |
Germany |
| Klages, Utz (Bayer 202308 Media Relations) |
Public Relations Manager / Investor Relations Manager |
Bayer (Group) |
Germany |
| Klann, Günter (Omnilab (D) 200903 Managing Director) |
Managing Director |
Omnilab (DE) (Group) |
Germany |
| Klapproth, Peter (Microstim 201309 Managing Director + Co-founder) |
Managing Director |
Microstim GmbH |
Germany |
| Klaue, Daniel (Zellmechanik Dresden 202011 Managing Director) |
Managing Director |
Zellmechanik Dresden GmbH |
Germany |
| Klaue, Thomas (Injex Pharma AG 201312 CEO) |
Chief Executive Officer (CEO) |
Injex Pharma AG |
Germany |
| Klaus, Uwe (Saxonia BioTec 200411 Managing Director) |
Managing Director |
Saxonia BioTec GmbH |
Germany |
| Klauschen, Frederick (Charité 202008 Prof + Deputy Director of Institute of Pathology) |
Professor |
Humboldt University Berlin |
Germany |
| Klausener, Alexander (Bayer 201112 Head of Research at Bayer CropScience) |
Research & Development Manager |
Bayer (Group) |
Germany |
| Klausner, Richard (Rick) (Lyell Immunopharma 201910 CEO + Founder before Juno Therapeutics + NCI) |
Chief Executive Officer (CEO) |
Lyell Immunopharma, Inc. |
United States (USA) |
| Klebe, Martin (Univ Marburg 201502 Professor) |
Professor |
University of Marburg (Philipps-Universität Marburg) |
Germany |
| Klebl, Bert (Lead Discovery Center 200806– CEO) |
Managing Director |
Max Planck Society for the Advancement of Science |
Germany |
| Kleczkowska, Hanna (Helsinn 201709 Helsinn Investment Fund) |
Investment Manager |
Helsinn (Group) |
Luxembourg |
| Kleemann, Axel (Asta Medica 1987–2000 before Degussa ua) |
Board member |
Æterna Zentaris (Group) |
Germany |
| Klein, Christoph (Univ Regensburg 201902 + Fraunhofer ITEM 201902) |
Researcher (university / research institute) |
University of Regensburg |
Germany |
| Klein, Christopher (Numaferm 202305 Managing Directror, CFO + Head of IR) |
Managing Director |
Numaferm GmbH |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 37 38 39 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
